Published mark

Edesa Biotech, Inc.

NASDAQ: EDSA. Canonical company identity and public leadership record.

US

Record source reportedRecord not claimedNo Eval published
Follow companySave PDF
Alpha ID
alpha:company:a858f180-d27c-4533-94ab-2b7224f2958f
SEC CIK
0001540159
Record version
vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce, published Oct 8, 2026
Newest evidence
Apr 3, 2026
Monitoring
Not yet monitored Details
Integrity
Not yet signed Methodology
CEO
Not published
Chair
Not published
Independent
6 / 77 directors published
Published claims
243 distinct sources
Evidence records
50 pinned
Source conflicts
0None open

Built from 3 distinct sources and 5 evidence records. Every Claim links to where it appears. Where nothing was published, the record states the coverage gap.

CorroboratedSource reportedAlpha inferenceNot disclosed

Public record. Alpha publishes governance facts about this organization from regulatory filings and company statements. Private enterprise overlay data is never projected here. The company can claim the record, correct, or dispute any Claim. How this works

EXECUTIVE APPOINTED

Michael Brooks, PhD executive of Edesa Biotech, Inc., effective 2025-12-12.

EffectiveEffective Dec 12, 2025E3

Monitoring

Continuous

What the published record states about identity, evidence, evaluation, monitoring, authority, and freshness. Watched-source schedules are not published for this record.

  • Identityunclaimed
    Published
  • Evidencesource_reported
    Published
  • Evaluationnot_evaluated
    Published
  • MonitoringNot yet published for this record.
    Not published
  • AuthorityNot yet published for this record.
    Not published
  • Freshnesscurrent
    Published

Leadership

Evidence
RolePersonSinceStatusClaim
PresidentMichael Brooks, PhDDec 2025currentSource reportedE3
Chief Financial OfficerPeter WeilerDec 2025currentSource reportedE4

Board of directors

Evidence

7 directors published. 6 of 7 with a published determination are independent.

DirectorStatusSinceCommitteesClaim
Carlo Sistilli, CPA, CMAIndependent2019Audit, chairAudit · ChairSource reportedE2
Charles Olson, DScIndependent2023CompensationCompensation; Nominating and GovernanceNominating and GovernanceSource reportedE2
David Liu, PhDIndependent2025CompensationSource reportedE2
Joan ChypyhaIndependent2023AuditAudit; CompensationCompensationSource reportedE2
Pardeep Nijhawan, MDNot independent2019None publishedSource reportedE2
Patrick MarshallIndependent2023AuditAudit; Nominating and Governance · ChairNominating and Governance, chairSource reportedE2
Sean MacdonaldIndependent2019None publishedSource reportedE2

Committees and risk ownership

Evidence
CommitteeChairMembersRisks assigned
AuditCarlo Sistilli, CPA, CMACarlo Sistilli, CPA, CMA, Joan Chypyha, Patrick Marshall, Carlo Sistilli, CPA, CMA, Joan Chypyha, Patrick MarshallNot described in the published record
Audit · ChairNot publishedCarlo Sistilli, CPA, CMANot described in the published record
Audit; CompensationNot publishedJoan ChypyhaNot described in the published record
Audit; Nominating and Governance · ChairNot publishedPatrick MarshallNot described in the published record
CompensationNot publishedCharles Olson, DSc, David Liu, PhD, Joan Chypyha, Charles Olson, DSc, David Liu, PhD, Joan Chypyha, David Liu, PhDNot described in the published record
Compensation; Nominating and GovernanceNot publishedCharles Olson, DScNot described in the published record
Nominating and GovernancePatrick MarshallPatrick Marshall, Charles Olson, DSc, Patrick Marshall, Charles Olson, DScNot described in the published record
Committee RecordAudit: Chair Carlo Sistilli, CPA, CMA; Members Carlo Sistilli, CPA, CMA (Chair); Joan Chypyha; Patrick Marshall
Source reportedE5
company:a858f180-d27c-4533-94ab-2b7224f2958f:committee_record:14
Committee AppointmentCarlo Sistilli, CPA, CMA: chair, Audit
Source reportedE5
company:a858f180-d27c-4533-94ab-2b7224f2958f:committee_appointment:15
Committee AppointmentJoan Chypyha: member, Audit
Source reportedE5
company:a858f180-d27c-4533-94ab-2b7224f2958f:committee_appointment:16
Committee AppointmentPatrick Marshall: member, Audit
Source reportedE5
company:a858f180-d27c-4533-94ab-2b7224f2958f:committee_appointment:17
Committee RecordCompensation: Chair not stated; Members Charles Olson, DSc; David Liu, PhD; Joan Chypyha
Source reportedE5
company:a858f180-d27c-4533-94ab-2b7224f2958f:committee_record:18
Committee AppointmentCharles Olson, DSc: member, Compensation
Source reportedE5
company:a858f180-d27c-4533-94ab-2b7224f2958f:committee_appointment:19
Committee AppointmentDavid Liu, PhD: member, Compensation
Source reportedE5
company:a858f180-d27c-4533-94ab-2b7224f2958f:committee_appointment:20
Committee AppointmentJoan Chypyha: member, Compensation
Source reportedE5
company:a858f180-d27c-4533-94ab-2b7224f2958f:committee_appointment:21
Committee RecordNominating and Governance: Chair Patrick Marshall; Members Patrick Marshall (Chair); Charles Olson, DSc
Source reportedE5
company:a858f180-d27c-4533-94ab-2b7224f2958f:committee_record:22
Committee AppointmentPatrick Marshall: chair, Nominating and Governance
Source reportedE5
company:a858f180-d27c-4533-94ab-2b7224f2958f:committee_appointment:23
Committee AppointmentCharles Olson, DSc: member, Nominating and Governance
Source reportedE5
company:a858f180-d27c-4533-94ab-2b7224f2958f:committee_appointment:24

Control and voting power

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Authority to act

Evidence and agent registry

Who can act for the company, and on whose authority. This is what a counterparty's agent checks before it accepts an order, signs, or pays.

Who can authorize an agentNot assessedNo Alpha inference about signing authority or board-reserved matters is published for this record.
Not assessed
bind
AI agents registered by the companyNot registered in the public RegistryAgent Deployments, Agent Use Cases, Authority Grants, TrustChecks, Action Ledger entries and Governance Receipts live in the private enterprise overlay. They are never projected into the public Registry without explicit cross-plane authorization. Absence here is a plane boundary, not evidence that the enterprise operates no agents.
Agent registry
agents
Delegations publishedNot disclosedBoard and officer delegation resolutions are not public filings and are not published in this record.
Search scope
delegations

Financials and market context

Evidence
Security ListingEDSA (NASDAQ)
Source reportedE1
company:a858f180-d27c-4533-94ab-2b7224f2958f:security_listing:25
Index membershipsNo current membership is published in Alpha's tracked index universe.This is not evidence that the company is absent from every market index.
None publishedAs of Oct 8, 2026. Rights-filtered public evidence only; no redistribution or model training is granted. Only source-backed memberships with an explicit public redistribution basis are returned.

Governance and policies

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Risk, audit, and cyber

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

AI oversight and accountability

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Compensation

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Other published claims

Evidence

Published Claims that belong to no section above. Each keeps its permalink, evidence, and assertion state.

Legal NameEdesa Biotech, Inc.
Source reportedE1
company:a858f180-d27c-4533-94ab-2b7224f2958f:legal_name:1
Entity StatusPublic listing published
Source reportedE1
company:a858f180-d27c-4533-94ab-2b7224f2958f:entity_status:3

Not yet in this record

Coverage

A gap is a coverage state, not a negative finding. These sections are expected for this entity class and are not yet published.

  • Corporate structureNot reviewed. Parent, subsidiary and predecessor structure explains who is governed.
  • OwnershipNot reviewed. Ownership and voting power determine who can influence the board.
  • FinancialsNot reviewed. Governance-relevant financial context frames capital and audit decisions.
  • CompensationNot reviewed. Pay design shows how incentives are governed.
  • GovernanceNot reviewed. Governing documents and provisions set the rules of the enterprise.
  • Shareholder governanceNot reviewed. Meeting and vote records show shareholder dissent and support.
  • AuditNot reviewed. Auditor, controls and restatements show assurance over reporting.
  • LegalNot reviewed. Material legal and regulatory matters show enforcement exposure.
  • RiskNot reviewed. Risk ownership links the board, committees, executives and controls.
  • CyberNot reviewed. Cyber and data governance is a disclosed oversight domain.
  • AI governanceNot reviewed. AI oversight is a differentiated Alpha governance domain.
  • Markets externalNot reviewed. Auditors, advisors, investors and regulators form the external ecosystem.
  • Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
  • Only explicitly published canonical company identity and current confirmed public roles are included.Only explicitly published canonical company identity and current confirmed public roles are included.
  • Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
  • Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
  • This Company Profile is an identity and evidence record, not an Alpha rating.This Company Profile is an identity and evidence record, not an Alpha rating.

Subject and corrections

Public-role doctrine

This record exists because the company is in the published Registry. The company can claim the record, correct, or dispute any Claim. Corrections are versioned and the original stays in history.

Basis
Published company record built from public sources
Sources
5 evidence records cited. 0 with redistribution rights.
Never published
Private enterprise overlay data: deployments, authority grants, TrustChecks, receipts, telemetry
Record claimed
No
Open disputes
0
Identity ownership
unclaimed
Claiming not yet available

If the company claims the record, its statements appear as their own assertion state and never overwrite the cited evidence.

Evidence

Authority and rights
  1. E1
    Alpha canonical company public projection
    Alpha canonical company public projection. canonical identity. Retrieved Oct 8, 2026. Cited by 4 Claims.
    Open web
    Rights not recorded, link only
    Evidence not pinned
  2. E2
    Edesa Biotech, Inc. DEF 14A 2026-04-03
    sec proxy. Published Apr 3, 2026. Retrieved Apr 24, 2026. Cited by 7 Claims.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  3. E3
    EDSA 10-K executive officers
    sec filing. Published Dec 12, 2025. Retrieved May 16, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  4. E4
    EDSA 10-K executive officers
    sec filing. Published Dec 12, 2025. Retrieved May 16, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  5. E5
    Audit
    board_seats. board seats. Cited by 11 Claims.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned

What changed in version public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce

vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce published Oct 8, 2026
  • Michael Brooks, PhD executive of Edesa Biotech, Inc., effective 2025-12-12.
  • Peter Weiler executive of Edesa Biotech, Inc., effective 2025-12-12.
  • David Liu, PhD seat on Edesa Biotech, Inc., effective 2025-01-01.
  • David Liu, PhD member of Compensation, effective 2025-01-01.
  • Charles Olson, DSc seat on Edesa Biotech, Inc., effective 2023-01-01.
  • Joan Chypyha seat on Edesa Biotech, Inc., effective 2023-01-01.
  • Patrick Marshall seat on Edesa Biotech, Inc., effective 2023-01-01.
  • Audit; Compensation committee of Edesa Biotech, Inc., effective 2023-01-01.
  • Joan Chypyha member of Audit; Compensation, effective 2023-01-01.
  • Audit; Nominating and Governance · Chair committee of Edesa Biotech, Inc., effective 2023-01-01.
  • Patrick Marshall member of Audit; Nominating and Governance · Chair, effective 2023-01-01.
  • Compensation; Nominating and Governance committee of Edesa Biotech, Inc., effective 2023-01-01.
  • Charles Olson, DSc member of Compensation; Nominating and Governance, effective 2023-01-01.
  • Carlo Sistilli, CPA, CMA seat on Edesa Biotech, Inc., effective 2019-01-01.
  • Pardeep Nijhawan, MD seat on Edesa Biotech, Inc., effective 2019-01-01.
  • Sean Macdonald seat on Edesa Biotech, Inc., effective 2019-01-01.
  • Audit · Chair committee of Edesa Biotech, Inc., effective 2019-01-01.
  • Carlo Sistilli, CPA, CMA member of Audit · Chair, effective 2019-01-01.
Appearance

Alpha Governance PBC. The Registry records reported facts and Alpha's assessments separately. A missing fact is not evidence that it is false.

Record alpha:company:a858f180-d27c-4533-94ab-2b7224f2958f, version public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce. https://registry.alpha.ac/companies/edesa-biotech-inc

Navigate

On this record

  1. Overview
  2. Monitoring4
  3. Leadership2
  4. Board7
  5. Committees7
  6. Control and voting0
  7. Authority to act3
  8. Financials1
  9. Governance0
  10. Risk0
  11. AI oversight0
  12. Legal0
  13. Compensation0
  14. Other published claims3
  15. Coverage gaps17
  16. Linked people9
  17. Subject and corrections6
  18. Evidence5
  19. Version historyvpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce

Linked records

Registry

Appearance

esc
  • Actions
    Switch to agent viewJSON, Markdown, MCP
  • Copy Alpha IDalpha:company:a858f180-d27c-4533-94ab-2b7224f2958f
  • Cite this recordEdesa Biotech, Inc.
  • Copy canonical URLregistry.alpha.ac/companies/edesa-biotech-inc
  • Copy as MarkdownWith assertion states
  • Report an error
  • Theme: System
  • Theme: Light
  • Theme: Dark
  • Records
    Edesa Biotech, Inc.Company
  • Michael Brooks, PhDPerson
  • Peter WeilerPerson
  • Carlo Sistilli, CPA, CMAPerson
  • Charles Olson, DScPerson
  • David Liu, PhDPerson
  • Joan ChypyhaPerson
  • Pardeep Nijhawan, MDPerson
  • Patrick MarshallPerson
  • Sean MacdonaldPerson
  • Sections
    OverviewEdesa Biotech, Inc.
  • MonitoringEdesa Biotech, Inc.
  • LeadershipEdesa Biotech, Inc.
  • BoardEdesa Biotech, Inc.
  • CommitteesEdesa Biotech, Inc.
  • Control and votingEdesa Biotech, Inc.
  • Authority to actEdesa Biotech, Inc.
  • FinancialsEdesa Biotech, Inc.
  • GovernanceEdesa Biotech, Inc.
  • RiskEdesa Biotech, Inc.
  • AI oversightEdesa Biotech, Inc.
  • LegalEdesa Biotech, Inc.
  • CompensationEdesa Biotech, Inc.
  • Other published claimsEdesa Biotech, Inc.
  • Coverage gapsEdesa Biotech, Inc.
  • Linked peopleEdesa Biotech, Inc.
  • Subject and correctionsEdesa Biotech, Inc.
  • EvidenceEdesa Biotech, Inc.
  • Version historyEdesa Biotech, Inc.
↑ ↓ move↵ openThis record only

Report an error

Reports attach to the Claim and go to an Alpha analyst through the correction form. Corrections are versioned, and the original stays in history.